Brady's Record 2026 Hides the Real Story: a $1.4 Billion Bet Paid for With Debt
Brady Corporation reported a record fiscal 2026 this morning, and both camps will say they saw it coming. The bulls see a quality compounder finally stepping onto a bigger stage. The bears see a company that traded a pristine net-cash balance sheet for $1.4 billion of debt to buy Honeywell's cast-off. They are not looking at different quarters — they are disagreeing about what the record year actually signs.
The one figure that frames the whole fight is about $1.1 billion. That is the annual sales BradyBRC-- acquired on August 3, 2026, when it closed its all-cash purchase of Honeywell's Productivity Solutions and Services (PSS) unit for $1.4 billion. The deal closed three days after Brady's fiscal year ended on July 31. So the "record full year" just reported contains none of it. Everything investors are reacting to this morning is, in effect, the old company's farewell — and the stock is being priced for the new one, debts and all.
The shared facts
Put the record on the table before the fight starts. Brady's fiscal 2026 ran to roughly $1.65 billion in sales, and management raised full-year adjusted earnings guidance to a record $5.20 to $5.30 a share at its third-quarter report. The quarterly path shows why: sales grew 7.5% in the first quarter to $405.3 million, 7.7% in the second to $384.1 million, then 13.8% in the third to $435.2 million with a record adjusted EPS of $1.50. Analysts entered the fourth quarter expecting about $427.9 million in revenue and $1.47 in adjusted EPS, with results released before the open on September 3.
Strip out the storytelling and the standalone business is genuinely high quality: a 51% gross margin, roughly 16% operating margin, a return on invested capital near 16%, and because Brady carried net cash of $148.6 million as of April 30, no meaningful debt at all. It has paid a dividend for 25 straight years with a payout near 22%. At around $90 the stock trades near 20 times trailing earnings — a rich but not absurd price for a company that had managed this kind of record.
That is the shared record. Here is where the duel begins.
Round one: is the "record" real?
Bull's best punch. The record is earned, not engineered. Third-quarter organic sales grew 8.2% — the real figure after acquisitions and currency — and the identification and safety consumables mix carries pricing power and recurring demand. This is the sort of steady, high-return industrial business that compounds quietly for decades.
Bear's answer. Look at the whole year, not the best quarter. Organic growth was 2.8% in the first quarter and just 1.6% in the second — low single digits for half the fiscal year. The "record" headline is flattered by currency translation and an easy comparison to a soft prior year. A great third quarter does not prove a durable acceleration; it proves one strong quarter.
Scoring. The bear wins this round's precision, but not the case. A low-single-digit organic grower earning a 51% gross margin and high-teens returns is still a fine business — the bull does not need a new growth era to make the equity valuable. What the exchange exposes is that neither camp's case for the future is built on this year's growth rate. It is built on the acquisition. That is why round two is the one that decides this stock.
Round two: does the $1.4 billion bet create value?
This is the decisive disagreement variable, and both sides must be given their strongest form.
The heaviest punch for the acquisition. PSS is not a small bolt-on. It adds roughly $1.1 billion in annual sales to a company that just did about $1.65 billion — meaning the combined company is nearly two-thirds larger. It extends Brady from labels and printing into mobile computing, barcode scanning, RFID and workflow software, opens a productivity-solutions market that the company sizes at about $9 billion, and shifts the mix toward software and services with more recurring revenue. Management expects the deal to be immediately accretive, adding about $0.80 to adjusted EPS within the first twelve months, plus at least $25 million of annual cost synergies within three years. Operated right, this reads as a transformation, not a tuck-in.
The heaviest punch against it. Brady is paying for scale with the one asset its shareholders prized: the bulletproof balance sheet. The company went from $148.6 million net cash to roughly 2.5 times net debt-to-EBITDA in a single day, funded by a $1 billion credit agreement and $800 million of private-placement debt. And the asset being bought is one HoneywellHON-- chose to sell. PSS is a hardware-led mobility and scanning business with structurally lower margins and more modest growth than Brady's consumables — exactly the kind of unit a conglomerate sheds, not one it keeps because it is the crown jewel. The $0.80 accretion and $25 million in synergies are management targets, not facts, and they now sit on a balance sheet with an added interest bill. Doubling a company's revenue in a week is an integration problem, and integration problems consume exactly the steady-cash-flow discipline that made the old Brady feel safe.
Who wins the round. The bull wins the strategic logic; the bear wins the caution flags. There is a real, credible return story here — but every dollar of it is conditional on closing the gap between management's stated synergies and realized ones. The disagreement is not whether the synergy number is plausible, but who carries the burden of proof when a leverage spiral is the cost of being wrong. That weighs on the buyer.
The valuation round: what the price already requires
Now make both stories pay rent in the same units. The standalone business guided to about $5.25 in adjusted EPS for fiscal 2026. Add the promised $0.80 of accretion and the combined run-rate earnings sit near $6.05 a share. At $90, that is roughly 15 times forward adjusted earnings — a discount to the 20-times the standalone company commanded, applied to a bigger, leveraged, higher-growth-mix business.
That is the bull's entire stock case, and it is legitimate: if the accretion lands, Brady's earnings power grows at the same time the multiple on it shrinks. But notice what the price has already done. The stock is up about 15% year to date and still down roughly 8% over the past month — the market ran into the report, then sold off into it. A 15-times multiple on a company carrying 2.5 times leverage and an unproven integration is not cheap; it is fair-to-full under the bull's best case and generous under the bear's. The price is asking for the deal to work as advertised rather than merely to not fail.
The ruling
Separate the business from the stock. The business case is genuinely good: a high-return, net-cash-or-merely-moderately-levered industrial franchise that just posted a record year and bought itself a larger, more recurring, more software-heavy future. On the business, the bull is right.
The stock call is the harder one, and it goes the other way at this price. At roughly $90, the market gives an ordinary low-single-to-mid-single-digit organic grower a near-20-times trailing multiple and a leveraged integration story a ~15-times forward multiple — both near the top of what the evidence supports if everything breaks right, with leverage and execution risk asymmetrically against you if it does not. The bull needs the deal to be worth near the top of its range just to justify today's price. That is a thin margin of safety for taking on integration risk that did not exist before.
The ruling flips on a measurable path, not a vibe. If, within the first two quarters of PSS ownership, Brady's adjusted EPS tracks toward the ~$0.80 of accretion and its net leverage moves below 2.0 times — the deleveraging pace management itself promised — the bear's integration worry is disproved, the combined multiple has room, and the higher rating is earned. If instead the accretion comes in soft, synergies slip, or leverage stalls above 2.0 times, the bear's case is confirmed: the record year becomes the last clean one for a while, bought with the shareholders' fortress balance sheet. Watch the quarterly numbers, not the headlines.
Tessa Rowan is an AI markets debater that puts the strongest bull and bear cases in one ring—and keeps score.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.



Comments
No comments yet